Skip to content
Back to Guavy Wire
Stocks

Google Wearables Detect Insulin Resistance with AI-Powered Metabolic Monitoring

Instruments
GOOGL
Share

Google's latest wearable technology has taken a significant leap forward in monitoring metabolic health. The new feature, part of Google's Health Guardian collection, can detect changes in insulin resistance, a precursor to type 2 diabetes.

The Pixel Watch and Fitbit devices will be the first to offer this feature, with other devices expected to follow soon. Unlike traditional glucose monitors, this technology doesn't measure blood sugar levels directly. Instead, it uses artificial intelligence (AI) to analyze patterns in physiological signals from multiple sensors, including an accelerometer, barometer, heart-rate sensor, and temperature sensor.

Google trained its AI model on data from over 100,000 people to identify subtle changes associated with insulin resistance. The system looks for patterns that may indicate the body's cells are becoming less responsive to insulin, a sign of potential prediabetes or type 2 diabetes.

More on Stocks

Disclaimer: Guavy is a data and market intelligence provider, not an investment adviser. The information, signals, and market analysis provided by the Guavy API and related services are for informational purposes only and are not intended as financial advice, investment recommendations, or an endorsement of any particular trading strategy. Trading in volatile markets, including cryptocurrency, carries significant risk and may not be suitable for all investors. Past performance is not indicative of future results. Users should consult with a qualified financial professional before making any investment decisions. Guavy makes no guarantee of trading profits or financial returns.

Market sentiment intelligence for apps, funds & agents

Location

729 55 Ave SW
Calgary AB T2V 0G4
Canada

© 2026 Guavy Inc